3Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of innate immune system? Diabetologia,1998 ,41:1241-1248.
4Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glacosedisorders in the elderly: the cardiovascular health study. Diabetes ,2001,50:2384-2389.
5Martens FM, Visseren FL, Lemay J, et al. Metabolic and additional vascular effects of thiazolidinediones. Drugs ,2002,62 : 1463-1480.
6Satoh, Noriko MD, Ogawa, et al. Antiatherogenic Effect of Pioglitazone in Type 2 Diabetic Patients Irrespective of the Responsiveness to Its Antidiabetic Effect. Diabetes Care.2003.26.2493-2499.
7Ridker PM, Rifal N, Rose L, et al. Comparison of C-creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med ,2002,347 : 1557-1565.
8Masabiko L, akihiko H, Hiroshi Y, et al. Pioglitazone reduces atherogenic outcomes in type 2 diabetic patients. J Atheroscler Thromb, 2008, 15:34-40.
9Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60 : risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke ,2002,33 : 1776-1781.
4Namvaran F,Azarpira N,Rahimi-Moghaddam P,et al.Polymorphism of peroxisome proliferator-activated receptory (PPAR-γ)Prol2Ala in the Iranian population:relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes[J] .Eur J Pharmacol,2011,671:1-6.
6Trifilieff A, Bench A, Hanley M, et al. PPAR-alpha and- gamma but not-delta agonists inhibit airway inflammation in a murine model of asthma:in vitro evidence for an NF- kappaB-independent effect[J]. Br J Pharmacol, 2003,139 (1) :163-171.
7Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and in- creased serum immunoglobulin E in inner-city adults[J]. Clin Exp Allergy, 2012,42 (5) : 747-759.
8Lee KS, Park SJ, Hwang P H, et al. PPAR-gamma modu- lates allergic inflammation through upregulation of PTEN [J]. FASEB J, 2005,19 (8): I033-i035.
9Sandhu MS,Dimov V,Sandhu AK,et al. The use of the peroxisome proliferator-activated receptors gamma ago- nist rosiglitazone to treat airway hyperreactivity[J]. Ann Allergy Asthma Immunol,2012,109(1) :75-77.
10Seppo TR,Laura CF,Bridget FC, et al. Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes:a cohort study[J]. Allergy Asthma Clin Immu- nol,2014,10(1) :34.
